|
FY2025
12 months to Dec 31, 2025
|
FY2024
5 months to Dec 31, 2024
|
|
|---|---|---|
| Cash flows from operating activities: | ||
| Net loss | ||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Depreciation and amortization | ||
| Non-cash operating lease expense | ||
| Stock-based compensation | ||
| Provision for inventory impairment | ||
| Impairment - Goodwill | ||
| Impairment - Intangibles assets, net | ||
| Change in fair value of convertible notes payable | ||
| Change in fair value of warrant liabilities | ||
| Net change in operating assets and liabilities: | ||
| Accounts receivable, net | ||
| Inventory, net | ||
| Prepaid expenses and other current assets | ||
| Accounts payable | ||
| Accrued liabilities | ||
| Accrued transaction costs | ||
| Other accrued liabilities | ||
| Operating lease liabilities | ||
| Other long-term liabilities | ||
| Deferred taxes | ||
| Net cash used in operating activities | ||
| Cash flows from investing activities: | ||
| Purchases of property and equipment | ||
| Net cash used in investing activities | ||
| Cash flows from financing activities: | ||
| Proceeds from the issuance of common shares, pre-funded warrants and warrants, net of $2,865 issuance costs | ||
| Net cash provided by financing activities | ||
| Effect of foreign currency translation on cash and cash equivalents | ||
| Net change in cash and cash equivalents | ||
| Cash and cash equivalents, at beginning of period | ||
| Prior to Effect of Business Combination | ||
| Total cash and cash equivalents, at beginning of period | ||
| Cash and cash equivalents, at end of period |
Loading...
